This federal contract award to Harmony Biosciences LLC is a $10,170 firm-fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration. The award is placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The...
This is a firm-fixed-price delivery order from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the prescription drug WAKIX (pitolisant). The order is valued at $5,085.00 and is being placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Harmony Biosciences, a for-profit pharmaceutical company specializing in rare neurological diseases...
This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract has an award ceiling value of $10,418.14 and is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the Department of Veterans Affairs (VA). The contract is for the provision of WAKIX 17.8 mg tablets, which are used to treat excessive daytime sleepiness and cataplexy in adult...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the pharmaceutical product WAKIX 17.8 MG. The order, valued at $10,418.40, was placed against the VA's $5 million Blanket Purchase Agreement with Harmony Biosciences to supply WAKIX, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients, to VA healthcare facilities nationwide. Harmony...
Harmony Biosciences LLC has been awarded a firm fixed price delivery order valued at $10,170 to supply WAKIX 17.8 MG tablets. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 against the General Services Administration Federal Supply Schedule for Pharmaceuticals and Drugs. Performance will take place in Pittsburgh, Pennsylvania by January 31, 2024. No set-aside designation was applied to this order to fulfill...
The Department of Veterans Affairs Veterans Health Administration awarded a $27,831.60 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Harmony Biosciences LLC. The order is for WAKIX 17.8MG NDC 72028-0178-03 to be delivered to locations in Plymouth Meeting, Pennsylvania, over a one year period from August 2023 through August 2024. Harmony Biosciences will provide the prescription drug as the prime contractor in support of the VA-VHA's healthcare programs for...
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, to provide WAKIX 17.8 mg tablets. The order, valued at $5,085.00, is issued against Harmony Biosciences' General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) contract. Harmony Biosciences has a $5 million Blanket Purchase Agreement with the VA National Acquisition Center to supply WAKIX, as well as...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC for the provision of WAKIX (pitolisant) 17.8 mg tablets. The $5,209.07 contract has an ultimate completion date of April 1, 2025 and is issued against the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Harmony Biosciences, a for-profit pharmaceutical company that specializes in neurological and sleep disorder treatments, has previously received...
This federal contract award to Harmony Biosciences LLC, a pharmaceutical company, is a delivery order against the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valued at $10,170.00, this firm-fixed-price order is for the medication WAKIX 17.8 MG, which is used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The order is placed by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to...
Harmony Biosciences LLC was awarded a $50,850 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply WAKIX tablets. The delivery order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule, also known as FSS-61-IB, with performance at the Plymouth Meeting, Pennsylvania location and completion by March 2025. No set-aside provision was applied to this order to fulfill the Veterans...